The isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate demonstrates the unique ability of increasing myocardial perfusion upon oral or intravenous administration. Methods of preparing the compound, its use in coronary conditions and pharmaceutical compositions for effecting that use are disclosed.
异丁基甲基1,4-二氢-2,6-二甲基-4-(2-
硝基苯基)-3,5-
吡啶二
羧酸二异
丙酯表现出口服或静脉注射后增加心肌灌注的独特能力。本文揭示了制备该化合物的方法,其在冠心病情况下的使用以及用于实现该使用的制药组合物。